美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
ALOGLIPTIN; METFORMIN HYDROCHLORIDE	210160	001	ANDA	ALOGLIPTIN; METFORMIN HYDROCHLORIDE	TABLET;ORAL	EQ 12.5MG BASE;500MG	No	No	2018/12/19 (TA)	--	TORRENT PHARMS LTD	None (Tentative Approval)
ALOGLIPTIN; METFORMIN HYDROCHLORIDE	210160	002	ANDA	ALOGLIPTIN; METFORMIN HYDROCHLORIDE	TABLET;ORAL	EQ 12.5MG BASE;1GM	No	No	2018/12/19 (TA)	--	TORRENT PHARMS LTD	None (Tentative Approval)
ALOGLIPTIN	210213	001	ANDA	ALOGLIPTIN BENZOATE	TABLET;ORAL	EQ 6.25MG BASE	No	No	2019/01/29 (TA)	--	MSN LABS PVT LTD	None (Tentative Approval)
ALOGLIPTIN	210213	002	ANDA	ALOGLIPTIN BENZOATE	TABLET;ORAL	EQ 12.5MG BASE	No	No	2019/01/29 (TA)	--	MSN LABS PVT LTD	None (Tentative Approval)
ALOGLIPTIN	210213	003	ANDA	ALOGLIPTIN BENZOATE	TABLET;ORAL	EQ 25MG BASE	No	No	2019/01/29 (TA)	--	MSN LABS PVT LTD	None (Tentative Approval)
ALOGLIPTIN AND METFORMIN HYDROCHLORIDE	210212	001	ANDA	ALOGLIPTIN AND METFORMIN HYDROCHLORIDE	TABLET; ORAL	12.5MG/500MG	No	No	2019/11/27 (TA)	--	MSN LABORATORIES PRIVATE LTD	None (Tentative Approval)
ALOGLIPTIN AND METFORMIN HYDROCHLORIDE	210212	002	ANDA	ALOGLIPTIN AND METFORMIN HYDROCHLORIDE	TABLET; ORAL	12.5MG/1000MG	No	No	2019/11/27 (TA)	--	MSN LABORATORIES PRIVATE LTD	None (Tentative Approval)
ALOGLIPTIN	210002	001	ANDA	ALOGLIPTIN BENZOATE	TABLET;ORAL	6.25MG	No	No	2019/12/23 (TA)	--	INDOCO REMEDIES	None (Tentative Approval)